Announcements Trials
Browse Landscape

Phase

Phase NA 23Phase 1 4Phase 2 2Phase 1/2 2Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 5Plasma cell 2Gastrointestinal 2Thoracic 1Lymphoid 1CNS 1

Conditions

Neoplasms, Plasma Cell 1Lymphoma 1Alzheimer Disease 1

Interventions

Cyclophosphamide 21fludarabine 12Rituximab 10Vincristine 6Etoposide 6Prednisone 5Doxorubicin 5pembrolizumab 4Radiotherapy 4Methotrexate 4Magnetic Resonance Spectroscopy 4Immunotherapy, Adoptive 4Granulocyte Colony-Stimulating Factor 4Filgrastim 4Dexamethasone 4venetoclax 3ibrutinib 3Nivolumab 3Imiquimod 3Ifosfamide 3Exercise 3Biopsy 368Ga-pentixafor 3fludarabine phosphate 2daratumumab 2Transplantation 2Stem Cell Transplantation 2Specimen Handling 2Sirolimus 2Roflumilast 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Blood Specimen Collection × Lymphoid × Clear all
NCT03371420 2023-04-18

PET Imaging of Subjects Using 124I-PU-AD

Samus Therapeutics, Inc.

Phase EARLY_PHASE1 Terminated
5 enrolled
LymphoidPlasma cell

Alzheimer Disease, Lymphoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡